Consequently, PTHrP derived from NKX2-8 silenced-breast cancer cells contribute to formation of pre-bone metastatic niche through alteration of RANKL/OPG ration via acting on osteoblasts, resulting in instigating osteoclastogenesis that led to metastatic bone destruction. This evidence concerns the gene NKX2-8 and breast cancer.